View Luisa's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
N/A
May 2016 - Present · 8 years and 7 months
N/A
Aug 2013 - Jan 2016 · 2 years and 5 months
Pfizer, Inc
N/A
Jul 2009 - Dec 2011 · 2 years and 5 months
Company Details
Inspection Readiness. Two words that can ignite worry, fear, and stress. At LMK, we work with our clients to alleviate those concerns and ensure that you are inspection ready from Day One. We believe that the clinical trial content is the foundation of every clinical trial, and a strong foundation is key to the overall health and stability of any clinical program. LMK takes a proactive approach and makes clinical trial content quality a top priority on an ongoing basis - from start through closeout - not just pending an inspection or trial completion. Don't let your content be a collection burden at the end of a trial! It is a management tool throughout the life of your trial. LMK can help you plan, collect, and maintain your clinical trial content cost effectively without jeopardizing quality. We offer our clients a combination of expertise, tools, processes, and extensive knowledge of the clinical drug development process. Our experts will assess your study requirements and processes and create a plan customized to meet your specific needs. LMK is a division of TransPerfect Life Sciences. TransPerfect Life Sciences provides a full suite of e-clinical, product development, language, and technology solutions to our clients. From idea to launch, we help you every step of the way.
Year Founded
2013
Social Media
LinkedinFacebookTwitter
Industry
Pharmaceutical Manufacturing
HQ Location
New York, NY 10001, US
Keywords
Document ManagementeTMFTMFQuality ControlPharmaceuticalComplianceQuality AssuranceeClinicalEducatioRegulatory
Discover More About Cleveland Clinic

Find verified contacts of Luisa Monica in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.